← All stocks

Regeneron Pharmaceuticals

REGN Mostly scheduled

CIK 0000872589 #390 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$12.91M

$2.44M on a plan · $10.19M straight out of an exercise

Sold at will

$280.77K

1 of 84 sales

Net

−$12.91M

−$280.77K against sales at will

By person

20 insiders · 92 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

POON CHRISTINE A

Director

—

$4.25M (6) scheduled

−$4.25M

5,219

0.005%

$4.47M

+140.3%

McCourt Marion

EVP Commercial

—

$2.00M (2) scheduled

−$2.00M

12,222

0.012%

$10.48M

−7.1%

Zoghbi Huda Y

Director

—

$1.92M (12) scheduled

−$1.92M

1,703

0.002%

$1.46M

+23.2%

Pitofsky Jason

SVP Controller

—

$1.87M (12) scheduled

−$1.87M

4,272

0.004%

$3.66M

+1.6%

Bassler Bonnie L

Director

—

$1.77M (2) scheduled

−$1.77M

1,703

0.002%

$1.46M

+23.2%

Guarini Kathryn

Director

—

$660.00K (2) scheduled

−$660.00K

603

<0.001%

$517.01K

+113.8%

RYAN ARTHUR F

Director

—

$434.68K (48) scheduled

−$434.68K

17,303

0.017%

$14.84M

−2.1%

YANCOPOULOS GEORGE

Bd. Co-Chair, President & CSO

—

310,460

0.302%

$266.19M

+5.1%

SCHLEIFER LEONARD S

Bd. Co-Chair, President & CEO

—

214,523

0.209%

$183.93M

+8.9%

STAHL NEIL

EVP Research and Development

—

48,829

0.047%

$41.87M

−1.6%

MURPHY ANDREW J

EVP Research

—

47,833

0.047%

$41.01M

−1.0%

LAROSA JOSEPH J

EVP General Counsel and Secret

—

36,373

0.035%

$31.19M

+24.9%

SING GEORGE L

Director

—

31,007

0.030%

$26.59M

+18.0%

Van Plew Daniel P

EVP & General Mgr, Industrial

—

21,673

0.021%

$18.58M

+6.4%

Fenimore Christopher R.

EVP Finance CFO

—

19,984

0.019%

$17.13M

+30.6%

GOLDSTEIN JOSEPH L

Director

—

6,703

0.007%

$5.75M

+5.0%

COLES N ANTHONY

Director

—

1,714

0.002%

$1.47M

+23.0%

BROWN MICHAEL S

Director

—

1,703

0.002%

$1.46M

+23.2%

Thompson Craig B.

Director

—

775

<0.001%

$664.48K

+70.7%

Schenkein David P

Director

—

603

<0.001%

$517.01K

+113.8%

Regeneron Pharmaceuticals

By person

Individual transactions

What was left out